3.27
price down icon5.49%   -0.19
after-market Dopo l'orario di chiusura: 3.27
loading
Precedente Chiudi:
$3.46
Aprire:
$3.38
Volume 24 ore:
1.42M
Relative Volume:
0.61
Capitalizzazione di mercato:
$554.34M
Reddito:
$25.55M
Utile/perdita netta:
$-341.97M
Rapporto P/E:
-1.1679
EPS:
-2.8
Flusso di cassa netto:
$-304.44M
1 W Prestazione:
+2.19%
1M Prestazione:
-18.45%
6M Prestazione:
-63.67%
1 anno Prestazione:
-68.31%
Intervallo 1D:
Value
$3.19
$3.44
Intervallo di 1 settimana:
Value
$3.15
$3.525
Portata 52W:
Value
$3.02
$10.72

Relay Therapeutics Inc Stock (RLAY) Company Profile

Name
Nome
Relay Therapeutics Inc
Name
Telefono
617-370-8837
Name
Indirizzo
399 BINNEY STREET, CAMBRIDGE
Name
Dipendente
261
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-21
Name
Ultimi documenti SEC
Name
RLAY's Discussions on Twitter

Confronta RLAY con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RLAY
Relay Therapeutics Inc
3.27 554.34M 25.55M -341.97M -304.44M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.01 128.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
744.83 81.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
571.00 34.69B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
233.07 30.17B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.66 26.02B 3.32B -860.46M -1.04B -8.32

Relay Therapeutics Inc Stock (RLAY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-10 Ripresa Goldman Buy
2024-09-10 Aggiornamento Jefferies Hold → Buy
2024-09-10 Downgrade Oppenheimer Outperform → Perform
2024-05-10 Aggiornamento Barclays Equal Weight → Overweight
2023-04-20 Aggiornamento Jefferies Underperform → Hold
2023-04-19 Aggiornamento Raymond James Outperform → Strong Buy
2023-04-13 Iniziato Raymond James Outperform
2023-02-03 Iniziato Oppenheimer Outperform
2022-09-30 Iniziato Barclays Equal Weight
2022-09-02 Iniziato Stifel Buy
2022-06-06 Iniziato Jefferies Underperform
2022-02-01 Iniziato Berenberg Buy
2021-07-21 Iniziato BofA Securities Buy
2020-12-15 Reiterato H.C. Wainwright Buy
2020-12-08 Iniziato JMP Securities Mkt Outperform
2020-11-05 Iniziato H.C. Wainwright Buy
2020-08-10 Iniziato Cowen Outperform
2020-08-10 Iniziato Goldman Buy
2020-08-10 Iniziato Guggenheim Buy
2020-08-10 Iniziato JP Morgan Neutral
Mostra tutto

Relay Therapeutics Inc Borsa (RLAY) Ultime notizie

pulisher
Mar 10, 2025

Relay Therapeutics’ (RLAY) Buy Rating Reiterated at HC Wainwright - Armenian Reporter

Mar 10, 2025
pulisher
Mar 09, 2025

HC Wainwright Reiterates “Buy” Rating for Relay Therapeutics (NASDAQ:RLAY) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Acquires 13,532 Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

New York State Common Retirement Fund Has $121,000 Stock Holdings in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Down -31.1% in 4 Weeks, Here's Why You Should You Buy the Dip in Relay Therapeutics (RLAY) - Yahoo Finance

Mar 05, 2025
pulisher
Mar 02, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Mar 02, 2025
pulisher
Mar 01, 2025

The Goldman Sachs Group Lowers Relay Therapeutics (NASDAQ:RLAY) Price Target to $18.00 - Defense World

Mar 01, 2025
pulisher
Mar 01, 2025

Relay Therapeutics (NASDAQ:RLAY) Sets New 1-Year Low After Analyst Downgrade - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Relay Therapeutics price target lowered to $12 from $21 at Citizens JMP - TipRanks

Feb 28, 2025
pulisher
Feb 28, 2025

Relay Therapeutics stock target cut to $12 at Citizens JMP - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Buy Rating for Relay Therapeutics Driven by Strategic Advancements and Promising Clinical Trial Developments - TipRanks

Feb 28, 2025
pulisher
Feb 27, 2025

RLAY stock touches 52-week low at $3.34 amid market challenges - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Relay Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 26, 2025

Relay Therapeutics Reports 2024 Financial Results and Progress - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Relay Therapeutics reports Q4 EPS (45c), consensus (55c) - TipRanks

Feb 26, 2025
pulisher
Feb 26, 2025

Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - The Manila Times

Feb 26, 2025
pulisher
Feb 26, 2025

Relay Therapeutics, Inc. SEC 10-K Report - TradingView

Feb 26, 2025
pulisher
Feb 25, 2025

What To Expect From Relay Therapeutics Inc (RLAY) Q4 2024 Earnin - GuruFocus.com

Feb 25, 2025
pulisher
Feb 25, 2025

What To Expect From Relay Therapeutics Inc (RLAY) Q4 2024 Earnings - Yahoo Finance

Feb 25, 2025
pulisher
Feb 24, 2025

Relay Therapeutics to Participate in Two Upcoming Investor Conferences - WICZ

Feb 24, 2025
pulisher
Feb 24, 2025

Can These Two Major Healthcare Conferences Reveal Relay Therapeutics' Next Big Move? - StockTitan

Feb 24, 2025
pulisher
Feb 23, 2025

Relay Therapeutics (RLAY) to Release Earnings on Wednesday - MarketBeat

Feb 23, 2025
pulisher
Feb 20, 2025

Savant Capital LLC Buys Shares of 29,088 Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Feb 20, 2025
pulisher
Feb 20, 2025

Relay Therapeutics (RLAY) Projected to Post Quarterly Earnings on Thursday - Defense World

Feb 20, 2025
pulisher
Feb 20, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025 - The Manila Times

Feb 20, 2025
pulisher
Feb 19, 2025

The Potential Rise in the Price of Relay Therapeutics Inc (RLAY) following insiders activity - Knox Daily

Feb 19, 2025
pulisher
Feb 19, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year - GlobeNewswire

Feb 19, 2025
pulisher
Feb 19, 2025

Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and ... - The Bakersfield Californian

Feb 19, 2025
pulisher
Feb 16, 2025

This Insider Has Just Sold Shares In Relay Therapeutics - Simply Wall St

Feb 16, 2025
pulisher
Feb 15, 2025

Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock - MSN

Feb 15, 2025
pulisher
Feb 14, 2025

Relay Therapeutics (NASDAQ:RLAY) Shares Gap DownTime to Sell? - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sanjiv Patel Sells 75,324 Shares - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Insider Selling: Relay Therapeutics, Inc. (NASDAQ:RLAY) CEO Sells 140,182 Shares of Stock - MarketBeat

Feb 14, 2025
pulisher
Feb 14, 2025

Relay Therapeutics: A Precision Oncology Play Worth The Risk - Seeking Alpha

Feb 14, 2025
pulisher
Feb 13, 2025

Relay Therapeutics CEO Sanjiv Patel sells $818,399 in stock By Investing.com - Investing.com UK

Feb 13, 2025
pulisher
Feb 13, 2025

Q2 Earnings Forecast for RLAY Issued By Leerink Partnrs - MarketBeat

Feb 13, 2025
pulisher
Feb 11, 2025

Relay Therapeutics (NASDAQ:RLAY) Shares Gap Down – Should You Sell? - Defense World

Feb 11, 2025
pulisher
Feb 11, 2025

Q2 Earnings Estimate for RLAY Issued By Leerink Partnrs - Defense World

Feb 11, 2025
pulisher
Feb 10, 2025

Quarterly Metrics: Quick and Current Ratios for Relay Therapeutics Inc (RLAY) - The Dwinnex

Feb 10, 2025
pulisher
Feb 08, 2025

Brokers Issue Forecasts for RLAY Q1 Earnings - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

RLAY’s Market Whiplash: 9.47% YTD Rise, -1.31% Plunge in 30 Days - The InvestChronicle

Feb 07, 2025
pulisher
Feb 07, 2025

Analysts Set Expectations for RLAY Q1 Earnings - Armenian Reporter

Feb 07, 2025
pulisher
Feb 06, 2025

Healthy Upside Potential: Relay Therapeutics Inc (RLAY) - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

BlackRock, Inc. Expands Stake in Relay Therapeutics Inc with Sig - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Jefferies Upgrades Relay Therapeutics Inc (RLAY) to a Buy from a Hold - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

SG Americas Securities LLC Grows Position in Relay Therapeutics, Inc. (NASDAQ:RLAY) - Defense World

Feb 05, 2025
pulisher
Feb 05, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Receives Consensus Rating of “Moderate Buy” from Brokerages - ETF Daily News

Feb 05, 2025
pulisher
Feb 05, 2025

Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Feb 05, 2025
pulisher
Feb 04, 2025

How should investors view Relay Therapeutics Inc (RLAY)? - US Post News

Feb 04, 2025

Relay Therapeutics Inc Azioni (RLAY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$35.96
price up icon 0.98%
$21.98
price down icon 8.97%
$32.75
price down icon 0.79%
$317.87
price up icon 0.62%
$105.35
price down icon 3.15%
biotechnology ONC
$242.66
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):